Disclosed herein are methods for selectively treating pruritus in a subject having chronic prurigo (CP), including prurigo nodularis (PN), pharmaceutical compositions for use in the treatment of pruritus in a subject having CP or PN, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of pruritus in a subject having CP or PN.
本文公开了选择性治疗慢性瘙痒症(CP)(包括结节性瘙痒症(
PN))患者瘙痒症的方法、用于治疗CP或
PN患者瘙痒症的药物组合物、在制造治疗CP或
PN患者瘙痒症的药物中使用尼妥珠单抗或其等效物的方法。